Natus Medical (NTUS) Q1 2020 Earnings Call Transcript
NTUS earnings call for the period ending March 31, 2020.
Natus Medical
NTUS
NTUS
$21.87
$1.04
5.0%
Price as of May 26, 2020, 8:00 p.m. EDT
View Interactive NTUS Charts
A provider of healthcare products used for screening, detection, treatment, monitoring & tracking of common medical ailments such as hearing impairment, neurological dysfunction, epilepsy, sleep disorders, newborn jaundice & newborn metabolic testing.
Interactive Chart
News & Analysis: Natus Medical
The Fool has written over 100 articles on Natus Medical.
Here's Why NuVasive, Exelixis, and Natus Medical Fell Today
The healthcare companies couldn't sidestep the COVID-19 slump.
Natus Medical (NTUS) Q4 2019 Earnings Call Transcript
NTUS earnings call for the period ending December 31, 2019.
Natus Medical (NTUS) Q3 2019 Earnings Call Transcript
NTUS earnings call for the period ending September 30, 2019.
Natus Medical Is All Grown Up
This baby has a new ticker.
Natus Medical Inc (BABY) Q2 2019 Earnings Call Transcript
BABY earnings call for the period ending June 30, 2019.
Natus Medical Continues Its Restructuring
It's a rebuilding year for the medical device maker.
Natus Medical Inc (BABY) Q1 2019 Earnings Call Transcript
BABY earnings call for the period ending March 31 2019.
1 Surprising Reason Alzheimer's Drugs Remain So Elusive
Most biotech drugs focus on clearing plaques from brain cells, but restoring patients' sleep quality is also proving to be necessary.
Why Natus Medical Stock Dropped 18.1% in February
It wasn't just lower-than-expected earnings that hurt the medical device company.
![natusnewbornscreening_large1_large1_large1_large[1]](https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F200902%2Fnatusnewbornscreening_large1_large1_large1_large1.png&w=479&h=281&op=resize)
